Cancer Research

BD Announces CE Marking Of A New Molecular Test To Diagnose Patients With Clostridium Difficile Infections

SAN DIEGO, July 7 /PRNewswire/--- BD GeneOhm(TM) Cdiff Assay Submitted for FDA Clearance BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today the CE marking of the BD GeneOhm(TM) Cdiff molecular assay for the rapid ...

Article - Anna Ohlden - Jul 6 2008 - 11:30pm

The Scientific Business Of Thomson Reuters Examines The Hottest U.K. Institutions

PHILADELPHIA and LONDON, July 7 /PRNewswire/--- Survey Identifies Highest Impact Institutions, 2003-2007 The Scientific business of Thomson Reuters today announced results of a study assessing high-impact research by the United Kingdom's top-cited in ...

Article - Anna Ohlden - Jul 6 2008 - 11:30pm

Cellular 'Recycling' May Be Even Better Than The Environmental Kind

The jury is still out on the actual benefits of recycling as far as environmental impact but new research suggests that a cellular version could be useful for battling cancer. Scientists at Stanford University have identified a molecule that uses this unex ...

Article - News Staff - Jul 7 2008 - 12:49pm

European Medicines Agency (EMEA) Approves Relistor(TM) The First-in-Class Treatment Of Opioid-Induced Constipation (OIC) In Adva

MAIDENHEAD, England, July 7 /PRNewswire/--- First-in-Class Treatment set to Provide a New and Important Targeted Treatment for Distressing and near Universal Side Effect in Patients Receiving Opioids for Pain Relief as Part of Palliative Care Wyeth Pharma ...

Article - Anna Ohlden - Jul 7 2008 - 1:30pm

Understanding Epidemiology Could Lessen Impact Of Cancer False Positives

False-positive results are an inherent risk in cancer research, particularly in observational epidemiology studies. The frequency and impact of misleading results can be mitigated if researchers use more exacting standards when interpreting and reporting r ...

Article - News Staff - Jul 8 2008 - 4:40pm

Argyrin- Myxobacterial Agent May Be Natural Hope For New Cancer Therapy

The effective treatment of many forms of cancer continues to pose a major problem. Many tumors fail to respond to standard forms of chemotherapy or become resistant to the medication. Scientists at the Helmholtz Centre for Infection Research (HZI) in Braun ...

Article - News Staff - Jul 8 2008 - 8:06pm

Rosetta Genomics And Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary And Metastatic Tumors In

REHOVOT, Israel and JERSEY CITY, New Jersey, July 9 /PRNewswire/--- Study Demonstrates Differentiation of Primary Tumors From Metastases in the Brain With Accuracy Near 90%- Identifying Whether a Brain Malignancy is a Primary Tumor or a Metastasis is a Re ...

Article - Anna Ohlden - Jul 9 2008 - 8:33am

Food And The Brain (Hint: Eat More Fish)

In addition to helping protect us from heart disease and cancer, a balanced diet and regular exercise can also protect the brain and ward off mental disorders, says Fernando Gómez-Pinilla, a UCLA professor of neurosurgery and physiological science who has ...

Article - News Staff - Jul 9 2008 - 8:18pm

Danish Researchers Hack The Immune System's Key Codes

A group of researchers at the Technical University of Denmark and the University of Copenhagen have developed models of neural networks that make it possible to simulate how the body protects itself from disease and predict the immune system’s access codes ...

Article - News Staff - Jul 10 2008 - 10:23am

22 Genes That Control Embryonic Stem Cell Fate Identified

Scientists have identified about two dozen genes that control embryonic stem cell fate. The genes may either prod or restrain stem cells from drifting into a kind of limbo, they suspect. The limbo lies between the embryonic stage and fully differentiated, ...

Article - News Staff - Jul 10 2008 - 12:24pm